Literature DB >> 16405535

Endoscopic ultrasonography in patients with large gastric folds at endoscopy and biopsies negative for malignancy: predictors of malignant disease and clinical impact.

Angels Ginès1, Maria Pellise, Glòria Fernández-Esparrach, María Teresa Soria, Alfredo Mata, Alejandro Membrillo, Graciela Martínez-Pallí, Manel M Solé, Josep Llach, Josep M Bordas, Josep M Piqué.   

Abstract

OBJECTIVES: The aims of the study were to assess in patients with large gastric folds at endoscopy and endoscopic biopsies that tested negative for malignancy: (i) the predictive variables of malignancy in endoscopic ultrasonography (EUS), (ii) the impact of EUS.
METHODS: Patients with this condition evaluated with radial EUS (following the standard study protocol of our Unit in these patients) during a 5-yr period were included. Nine variables were evaluated as possible predictors of malignancy (chi2, t-test, and logistic regression procedure) using pathology results, or a minimum of 2 yr of follow-up as gold standard. Likelihood ratios (LR), pre-EUS, and post-EUS probabilities for the diagnosis of malignancy were used to assess the clinical impact of the technique.
RESULTS: Sixty-one patients were included (40 benign and 21 malignant). Predictive factors of malignancy were as follows: thickened gastric wall, thickened deep layers, impaired gastric distension, loss of the wall structure, and presence of ascites or lymph nodes, whereas the enlargement of superficial layers was a predictor of a benign condition. The enlargement of deep layers, as assessed by EUS was the only independent predictive factor for malignancy. When using this parameter, the pre-EUS probability of malignancy in our series (34%) increased up to 95% when EUS suggested malignancy (positive LR = 45), whereas it decreased to 4.7% when EUS precluded this diagnosis (negative LR = 0.102).
CONCLUSIONS: (i) The enlargement of deep layers is the only independent predictive factor for malignancy in patients with large gastric folds at endoscopy and biopsies testing negative for malignancy and (ii) EUS has a high clinical impact in these patients.

Entities:  

Mesh:

Year:  2006        PMID: 16405535     DOI: 10.1111/j.1572-0241.2005.00349.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  6 in total

1.  [Standards for diagnostics and therapy of gastric cancer].

Authors:  N Schulte; M Ebert
Journal:  Internist (Berl)       Date:  2014-08       Impact factor: 0.743

2.  Determination of the relationship between gastric wall thickness and body mass index with endoscopic ultrasound.

Authors:  Michael C Larsen; Brian M Yan; John Morton; Jacques Van Dam
Journal:  Obes Surg       Date:  2009-04-18       Impact factor: 4.129

3.  Endoscopic ultrasound of isolated gastric corrosive stricture mimicking linitis plastica.

Authors:  Ahmed Youssef Altonbary; Ahmed Galal Deiab; Emad Hamdy Negm; Mohamed Moustafa El Sorogy; Wagdi Fawzi Elkashef
Journal:  Endosc Ultrasound       Date:  2015 Jan-Mar       Impact factor: 5.628

Review 4.  A quarter century of EUS-FNA: Progress, milestones, and future directions.

Authors:  Irina Mihaela Cazacu; Adriana Alexandra Luzuriaga Chavez; Adrian Saftoiu; Peter Vilmann; Manoop S Bhutani
Journal:  Endosc Ultrasound       Date:  2018 May-Jun       Impact factor: 5.628

5.  Diffuse gastric cancer with peritoneal carcinomatosis can mimic Crohn's disease.

Authors:  C Hommel; M Knoedler; C Bojarski; M Schumann; H J Epple; M Zeitz; S Daum
Journal:  Case Rep Gastroenterol       Date:  2012-11-07

6.  Diagnosis and follow-up value of endoscopic ultrasonography (EUS) in primary gastric non-Hodgkin's lymphoma.

Authors:  Rong Fan; Tianyu Zhang; Xiangyi He; Wei Wu; Tingting Gong; Haiyang Lu; Shu Cheng; Huijuan Zhong; Weiguo Cao
Journal:  Transl Cancer Res       Date:  2021-02       Impact factor: 1.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.